34.4 %Among patients with type 1 diabetes (T1D), 34.4% cited cost of medications and test strips as a reason for insulin discontinuation.
Cameroundiabète de type 1observed 2016-2017published 2021Advances in therapyeurope_pmcdocument of 12 observations
94.23 %Against the susceptible Kisumu strain, LLINs washed with local soap showed 94.23% efficacy in Bertoua.
CamerounpaludismeHAL · Unilimdocument of 89 observations
No patients in either group had thyroglobulin autoantibodies.
Camerounthyroglobulin autoantibodiespublished 2006Clinical immunology (Orlando, Fla.)europe_pmcdocument of 10 observations
0.8 %The frequency of dual infections with HIV-1 group M and group O in Cameroon was 0.8% (95% confidence interval: 0.6–1.0%).
CamerounHIV-1 group M and group Oobserved 2006 to 2013published 2015Infection, genetics and evolution : journal of molecular epidemiology and evolutionary geneurope_pmcdocument of 4 observations
0.7 %The L33F mutation was identified in 0.7% of the 142 HIV-1 isolates in the protease gene.
CamerounVIH/sidapublished 2000Journal of Clinical MicrobiologyOpenAlexdocument of 19 observations
23.1 %Among 676 participants, obesity prevalence was 23.1%.
Camerounobésitépublished 2022Scientific reportseurope_pmcdocument of 3 observationsDOI 10.1038/s41598-022-07328-8
4.1 %The vertical transmission rate was 4.1% (34/837) among infants born to mothers on short-course ART.
CamerounVIH/sidaobserved November 2007 to October 2010published 2019Paediatrics and international child healthPubMeddocument of 7 observations
71 %Versions 1.0, 1.0+, and 1.5 detected 71, 100, and 100% of the subtype E-infected samples from patients, respectively.
CamerounVIH/sidapublished 1999Journal of Clinical MicrobiologyOpenAlexdocument of 6 observationsDOI 10.1128/jcm.37.1.110-116.1999
0.8 %The proportion of HBV-tested patients ranged from 0.8% to 72.5% according to the individual hospital.
Camerounhépatite Bpublished 2020BMC Infectious DiseasesOpenAlexdocument of 7 observationsDOI 10.1186/s12879-020-4784-7
26.4 %Among 458 patients who initiated antiretroviral therapy in rural district hospitals in Cameroon between 2006 and 2008, 121 (26.4%) were classified at WHO clinical stage 4.
CamerounVIH/sidaobserved 2006-2008published 2010Tropical medicine & international health : TM & IHeurope_pmcdocument of 7 observations
11.1 %The prevalence of the diabetic foot was 11.1% among outpatients.
Camerounpied diabétiquepublished 2005Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 10 observations
99.3 %The mortality rate of Royal Sentry against the susceptible Anopheles gambiae s.s. strain was 99.3% [95% CI 95.8–99.5%].
CamerounpaludismeHAL · Unilimdocument of 89 observations
0 %ZnT8 autoantibodies (ZnT8A) were not found in any of the 38 type 2 diabetic (T2D) subjects.
Cameroundiabète de type 2published 2017Clinical biochemistryeurope_pmcdocument of 7 observations
41.6 %Prevalence of diabetes based on HbA1c was higher than prevalence based on FPG in 41.6% of age-sex-survey groups.
Cameroundiabète (non précisé)published 2015The lancet. Diabetes & endocrinologyeurope_pmcdocument of 5 observationsDOI 10.1016/s2213-8587(15)00129-1
26.8 %Among 198 subjects with diabetic retinopathy, 53 (26.8%) had proliferative diabetic retinopathy in both eyes.
Camerounproliferative diabetic retinopathyobserved November 2007 to December 2008published 2010Sante (Montrouge, France)europe_pmcdocument of 8 observations
3.4 %The age-standardized prevalence of diabetes increased from 3.4% to 8.5% in men in sub-Saharan African countries between 1980 and 2014.
Cameroundiabète (non précisé)observed 1980published 2017International journal of epidemiologyeurope_pmcdocument of 11 observationsDOI 10.1093/ije/dyx078
355,900 casesIn 2021, there were 355900 total new cases of type 1 diabetes globally among children and adolescents aged 0–19 years.
Cameroundiabète de type 1observed 2021published 2022The lancet. Diabetes & endocrinologyeurope_pmcdocument of 4 observations
42 %Among 472 subjects with diabetes, 198 (42%) had diabetic retinopathy.
Cameroundiabetic retinopathyobserved November 2007 to December 2008published 2010Sante (Montrouge, France)europe_pmcdocument of 8 observations
0.7 %Global age-standardised prevalence of obesity in girls increased from 0.7% in 1975 to 5.6% in 2016.
Camerounobésitéobserved 1975published 2017Lancet (London, England)europe_pmcdocument of 12 observations
30.7 %Depressive symptoms (PHQ-9 score ≥5) were reported in 30.7% of patients with type 1 diabetes.
Cameroundepressive symptoms · diabète de type 1observed 2011published 2021Diabetes careeurope_pmcdocument of 4 observations
32.6 %Unknown causes accounted for 32.6% of 582 patients with severe hearing loss in Cameroon.
Camerounhearing losspublished 2013European journal of medical geneticseurope_pmcdocument of 8 observations
8 %Seroreactivity to B19 virus was recorded in 8% of chimpanzees and 27% of gorillas.
CamerounB19 viruspublished 2010Journal of VirologyOpenAlexdocument of 10 observations
96 patientsPlasma samples from 96 patients infected with various subtypes of HIV-1 were tested, including 55 infected with subtype A, 9 with subtype B, 21 with subtype C, 2 with subtype D, 7 with subtype E, and 2 with subtype G.
CamerounVIH/sidapublished 1999Journal of Clinical MicrobiologyOpenAlexdocument of 6 observationsDOI 10.1128/jcm.37.1.110-116.1999
1.6 %Phylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 2 (1.6%) remained unclassifiable.
CamerounVIH/sidapublished 2000AIDS Research and Human RetrovirusesOpenAlexdocument of 7 observations
1.3 odds_ratioThe adjusted odds ratio for prevalent screen-detected diabetes with each standard deviation higher waist circumference was 1.30 (95% CI: 1.16–1.46).
Camerounscreen-detected diabetesobserved 2006published 2015Diabetes research and clinical practiceeurope_pmcdocument of 5 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.